InsiderLens

fi_swedentransaction_report03 Sept 2021fi_sweden:9c500ce080a2ea6e040f8fa28424e024

fi_swedentransaction_report03 Sept 2021fi_sweden:f44c99428241447452358e207448ebe2

fi_swedentransaction_report28 May 2021fi_sweden:8c3729c537c0fbbb4a4f8d95777dc515

fi_swedentransaction_report28 May 2021fi_sweden:1d8144df1e6c6f5f15c868e22505973a

fi_swedentransaction_report28 May 2021fi_sweden:b960b37af259bfdad37cacea37518bed

fi_swedentransaction_report28 May 2021fi_sweden:64e822fca0d2a3d8adba6c04100f4570

fi_swedentransaction_report16 Oct 2020fi_sweden:2707db28dd87a6e848b14d5f75a7a06c

fi_swedentransaction_report10 Oct 2020fi_sweden:53beafd18e7ddb9ad69d6380fd41c496

fi_swedentransaction_report19 Mar 2020fi_sweden:dbbad265adce67fed5c6f2b999c7885b

fi_swedentransaction_report18 Mar 2020fi_sweden:fe3b84884ecb98e995abe6a9dfaaa76e

fi_swedentransaction_report25 Feb 2020fi_sweden:fb340d6abad7e8d08d377a7f71ff031d

fi_swedentransaction_report21 Feb 2020fi_sweden:784e1d65cd264c00a832fe7b3398905c

fi_swedentransaction_report18 Feb 2020fi_sweden:8ec9d28d4bb44dfe9e87b50d33ad67c7

fi_swedentransaction_report03 Feb 2020fi_sweden:945f52c1d0b2882444f48756cdd5aca7

fi_swedentransaction_report31 Jan 2020fi_sweden:9b65fa63e4a9c36b77d4631b1a1f0b33

fi_swedentransaction_report30 Jan 2020fi_sweden:19797fe2a06a0b2c5b9f1a1636a295a1

fi_swedentransaction_report12 Nov 2019fi_sweden:c8924892761da4de89c2a638d053a57e

fi_swedentransaction_report11 Nov 2019fi_sweden:62a4c0959d724a9961d97600b0acbe9d

fi_swedentransaction_report11 Nov 2019fi_sweden:6413e49684afee859c143686c84323af

fi_swedentransaction_report08 Nov 2019fi_sweden:c4c3a707e1aff2ab22f5a73a15ccbc3b

fi_swedentransaction_report06 Nov 2019fi_sweden:c78df963b7c49db0c543b91c611a3472

fi_swedentransaction_report04 Nov 2019fi_sweden:8f0a1a98ea180f877a10dd982cc5f763

fi_swedentransaction_report31 Oct 2019fi_sweden:69c29718507be40dbc154cec084c8f2d

fi_swedentransaction_report29 Oct 2019fi_sweden:6c316713ae6a99fb492b318f244705e1amend

fi_swedentransaction_report29 Oct 2019fi_sweden:91da7f1c7e98d2a7b331cd3425be5b19

Asarina Pharma AB.